The Global Microarrays Market is expected to grow at a CAGR of 7.24% as the demand for drug discovery, disease diagnostics, and precision medicine continues to accelerate.Austin, Texas, Jan. 26, 2026 ...

Prenatal imaging identified situs inversus totalis, and whole exome sequencing found DNAH11 variants. The case highlights how ...

The proteomics market is experiencing strong growth as demand rises for advanced tools that analyze protein structure, ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 5% year on year ...

For instance, some products that are used to perform various in vitro diagnostic tests using various technologies involve real time PCR detection systems, immunoassay systems, and others. In vitro ...

Twist Bioscience Corporation Q1 2026 revenue rose 17% and guidance increased. Click for this updated look at TWST stock ...

With Q3 behind us, let’s have a look at Illumina (NASDAQ:ILMN) and its peers. The life sciences tools and services sector ...

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $128.8, ...

Scientists at the University of Virginia School of Medicine are chasing a new way to slow glioblastoma, the deadliest brain ...

Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of life itself, as researchers learn to build quantum behavior directly into ...

The approach uses an iteration of the SHERLOCK technology exclusively licensed to OraSure Technologies' subsidiary, Sherlock Biosciences.

JPT is a key player in the world of peptides. They create special tools like peptide microarrays that help map out immune responses. They also offer services that speed up the creation of new ...